Live
CellExpansion and CAR engineering of granulocyte-monocyte progenitors for cellular immunotherapyEndpoints NewsBiopharma’s LGBTQ+ leaders; Novo Nordisk hacked?; and moreEndpoints NewsEndpoints News History: 10 Years, Bootstrap to FTClinical OMICsImproving HSV-2 Vaccine Efficacy with Combination StrategyCellMultimodal imaging of gene expression, morphology, and activity of the same neuron10x Genomics News10x Genomics, Cleveland Clinic Team Up on Bladder Cancer Diagnostics - Zacks Investment ResearchFierceBiotechFDA warning slams Zoll Medical with multiple quality control and reporting violationsBioWorldHangzhou Innogate Pharma discovers new KAT inhibitorsBioWorldAlicorn synthesizes new AAK1 inhibitorsBioWorldChinese scientists identify new macrocyclic compounds as kinase inhibitorsBioWorldNew VAV1 degradation inducers reported in Haisco Pharmaceutical Group patentsBioWorldNankai University and Accendatech present new majusculamide D derivatives
Lonza News Jan 21, 2026

Lonza Group (OTCMKTS:LZAGY) Trading Down 1.8% - What's Next? - MarketBeat

Lonza Group (OTCMKTS:LZAGY) Trading Down 1.8% - What's Next? - MarketBeat

Original
Body unavailable. Use the original source.